Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Lawrence Low Unit for
Policy Research in Science and Medicine, Wellcome Trust, London NW1 2BE
Correspondence to: Dr Wilkie
t.wilkie{at}wellcome.ac.uk
Objectives:
To gather empirical evidence on any
discrimination based on genetic information shown by the insurance
industry in the United Kingdom and to assess how society is likely to
handle future genetic information from tests for polygenic
multifactorial conditions.
Design:
Postal questionnaire survey.
Subjects:
Sample (n=7000) of members from seven
British support groups for families with genetic disorders and a
representative sample (n=1033) of the general public who answered
questions on applying for life insurance as part of an omnibus survey.
Main outcome measures:
Subjects were asked about their
experiences with insurers, the medical profession, employers, and
social services. Experiences with insurers are reported here.
Results:
Altogether 33.4% of the study group had
problems when applying for life insurance compared with 5% of
applicants in the omnibus survey. Thirteen per cent of study
respondents from subgroups who represented no adverse actuarial risk on
genetic grounds reported that their treatment by insurers seemed to
represent unjustified genetic discrimination.
Conclusions:
Life insurers may not be operating a
consistent policy for assessing genetic information or acting in accord
with the actuarial risks brought to them. The inconsistency suggests error rather than a corporate policy of discrimination based on genetic
characteristics. Any future proposals for genetic testing for common or
multifactorial disorders should be examined carefully.
Key messages
© BMJ 1998
Read all Rapid Responses